Cytek Biosciences Inc expected to post a loss of 3 cents a share - Earnings Preview

Cytek Biosciences

02/08/2024 21:43

* Cytek Biosciences Inc  CTKB.OQ   CTKB.O  is expected
to show a
fall in quarterly revenue when it reports  results on August 6
for the period ending June 30 2024
    * The Fremont California-based  company is expected to
report a
0.3% decrease in revenue to $49.526 million from $49.69 million
a year ago, according to the mean estimate from 5 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Cytek Biosciences Inc is
for a
loss of 3 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cytek
Biosciences
Inc is $9.00​, above​ its last closing price of $6.41. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.04       -0.04      -0.05     Missed  -25
 Jan. 1 0001   -0.01       0.00       0.04      Beat    1,101.
                                                        2
 Sep. 30 2023  0.02        0.03       0.00      Missed  -103.3
                                                        ​
 Jun. 30 2023  0.02        0.03       0.01      Missed  -66.7
 ​​Jan.        0.03        0.03       0.00      Missed  -100
 1 0001                                                 
 Dec. 31 2022  0.05        0.05       0.06      Beat    28.6​
 Sep. 30 2022  0.02        0.02       0.04      Beat    100
 Jan. 1 0001   0.03        0.02       0.03      Beat    80
 This summary was machine generated August 2 at 20:43 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)